533 related articles for article (PubMed ID: 33754147)
21. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
He X; Chandrashekar A; Zahn R; Wegmann F; Yu J; Mercado NB; McMahan K; Martinot AJ; Piedra-Mora C; Beecy S; Ducat S; Chamanza R; Huber SR; van Heerden M; van der Fits L; Borducchi EN; Lifton M; Liu J; Nampanya F; Patel S; Peter L; Tostanoski LH; Pessaint L; Van Ry A; Finneyfrock B; Velasco J; Teow E; Brown R; Cook A; Andersen H; Lewis MG; Schuitemaker H; Barouch DH
Cell; 2021 Jun; 184(13):3467-3473.e11. PubMed ID: 34133941
[TBL] [Abstract][Full Text] [Related]
22. Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques.
He Q; Mao Q; Zhang J; Gao F; Bai Y; Cui B; Liu J; An C; Wang Q; Yan X; Yang J; Song L; Song Z; Liu D; Yuan Y; Sun J; Zhao J; Bian L; Wu X; Huang W; Li C; Wang J; Liang Z; Xu M
Front Immunol; 2022; 13():949248. PubMed ID: 36059554
[TBL] [Abstract][Full Text] [Related]
23. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
Americo JL; Cotter CA; Earl PL; Liu R; Moss B
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
[TBL] [Abstract][Full Text] [Related]
24. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
[TBL] [Abstract][Full Text] [Related]
25. Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques.
Kaiser JA; Nelson CE; Liu X; Park HS; Matsuoka Y; Luongo C; Santos C; Ahlers LRH; Herbert R; Moore IN; Wilder-Kofie T; Moore R; Walker A; Yang L; Munir S; Teng IT; Kwong PD; Dowdell K; Nguyen H; Kim J; Cohen JI; Johnson RF; Garza NL; Via LE; Barber DL; Buchholz UJ; Le Nouën C
Nat Commun; 2024 Apr; 15(1):3553. PubMed ID: 38670948
[TBL] [Abstract][Full Text] [Related]
26. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys.
Le Nouën C; Nelson CE; Liu X; Park HS; Matsuoka Y; Luongo C; Santos C; Yang L; Herbert R; Castens A; Moore IN; Wilder-Kofie T; Moore R; Walker A; Zhang P; Lusso P; Johnson RF; Garza NL; Via LE; Munir S; Barber DL; Buchholz UJ
Cell; 2022 Dec; 185(25):4811-4825.e17. PubMed ID: 36423629
[TBL] [Abstract][Full Text] [Related]
27. Low-Dose Ad26.COV2.S Protection Against SARS-CoV-2 Challenge in Rhesus Macaques.
He X; Chandrashekar A; Zahn R; Wegmann F; Yu J; Mercado NB; McMahan K; Martinot AJ; Piedra-Mora C; Beecy S; Ducat S; Chamanza R; Huber SR; van der Fits L; Borducchi EN; Lifton M; Liu J; Nampanya F; Patel S; Peter L; Tostanoski LH; Pessaint L; Van Ry A; Finneyfrock B; Velasco J; Teow E; Brown R; Cook A; Andersen H; Lewis MG; Schuitemaker H; Barouch DH
bioRxiv; 2021 Jan; ():. PubMed ID: 33532782
[TBL] [Abstract][Full Text] [Related]
28. Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
Yu J; Collins ND; Mercado NB; McMahan K; Chandrashekar A; Liu J; Anioke T; Chang A; Giffin VM; Hope DL; Sellers D; Nampanya F; Gardner S; Barrett J; Wan H; Velasco J; Teow E; Cook A; Van Ry A; Pessaint L; Andersen H; Lewis MG; Hofer C; Burke DS; Barkei EK; King HAD; Subra C; Bolton D; Modjarrad K; Michael NL; Barouch DH
J Virol; 2022 Jan; 96(2):e0159921. PubMed ID: 34705557
[TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
[TBL] [Abstract][Full Text] [Related]
30. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Afkhami S; D'Agostino MR; Zhang A; Stacey HD; Marzok A; Kang A; Singh R; Bavananthasivam J; Ye G; Luo X; Wang F; Ang JC; Zganiacz A; Sankar U; Kazhdan N; Koenig JFE; Phelps A; Gameiro SF; Tang S; Jordana M; Wan Y; Mossman KL; Jeyanathan M; Gillgrass A; Medina MFC; Smaill F; Lichty BD; Miller MS; Xing Z
Cell; 2022 Mar; 185(5):896-915.e19. PubMed ID: 35180381
[TBL] [Abstract][Full Text] [Related]
31. Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice.
Lu M; Liu K; Peng Y; Ding Z; Li Y; Tendu A; Hu X; Gao G; Guo W; Liu H; Rao J; Zhao J; Chen M; Yuan Z; Wong G; Shan C; Yao Y; Lan J
Virol Sin; 2022 Aug; 37(4):581-590. PubMed ID: 35659605
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants.
Beavis AC; Li Z; Briggs K; Huertas-Díaz MC; Wrobel ER; Najera M; An D; Orr-Burks N; Murray J; Patil P; Huang J; Mousa J; Hao L; Hsiang TY; Gale M; Harvey SB; Tompkins SM; Hogan RJ; Lafontaine ER; Jin H; He B
bioRxiv; 2022 Jun; ():. PubMed ID: 35702147
[TBL] [Abstract][Full Text] [Related]
33. CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques.
Liu J; Yu J; McMahan K; Jacob-Dolan C; He X; Giffin V; Wu C; Sciacca M; Powers O; Nampanya F; Miller J; Lifton M; Hope D; Hall K; Hachmann NP; Chung B; Anioke T; Li W; Muench J; Gamblin A; Boursiquot M; Cook A; Lewis MG; Andersen H; Barouch DH
Sci Immunol; 2022 Nov; 7(77):eabq7647. PubMed ID: 35943359
[TBL] [Abstract][Full Text] [Related]
34. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
[TBL] [Abstract][Full Text] [Related]
35. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs.
Routhu NK; Cheedarla N; Gangadhara S; Bollimpelli VS; Boddapati AK; Shiferaw A; Rahman SA; Sahoo A; Edara VV; Lai L; Floyd K; Wang S; Fischinger S; Atyeo C; Shin SA; Gumber S; Kirejczyk S; Cohen J; Jean SM; Wood JS; Connor-Stroud F; Stammen RL; Upadhyay AA; Pellegrini K; Montefiori D; Shi PY; Menachery VD; Alter G; Vanderford TH; Bosinger SE; Suthar MS; Amara RR
Immunity; 2021 Mar; 54(3):542-556.e9. PubMed ID: 33631118
[TBL] [Abstract][Full Text] [Related]
36. Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
Ganesan S; Acosta H; Brigolin C; Orange K; Trabbic K; Chen C; Lien CE; Lin YJ; Lin MY; Chuang YS; Fattom A; Bitko V
PLoS One; 2022; 17(11):e0272594. PubMed ID: 36322572
[TBL] [Abstract][Full Text] [Related]
37. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques.
Nouën CL; Nelson CE; Liu X; Park HS; Matsuoka Y; Luongo C; Santos C; Yang L; Herbert R; Castens A; Moore IN; Wilder-Kofie T; Moore R; Walker A; Zhang P; Lusso P; Johnson RF; Garza NL; Via LE; Munir S; Barber D; Buchholz UJ
bioRxiv; 2022 May; ():. PubMed ID: 35665011
[TBL] [Abstract][Full Text] [Related]
38. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Ventura JD; Dinnon KH; Leist SR; Baric RS; Barouch DH
J Virol; 2021 Nov; 95(23):e0097421. PubMed ID: 34523968
[TBL] [Abstract][Full Text] [Related]
39. Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge.
King RG; Silva-Sanchez A; Peel JN; Botta D; Dickson AM; Pinto AK; Meza-Perez S; Allie SR; Schultz MD; Liu M; Bradley JE; Qiu S; Yang G; Zhou F; Zumaquero E; Simpler TS; Mousseau B; Killian JT; Dean B; Shang Q; Tipper JL; Risley CA; Harrod KS; Feng T; Lee Y; Shiberu B; Krishnan V; Peguillet I; Zhang J; Green TJ; Randall TD; Suschak JJ; Georges B; Brien JD; Lund FE; Roberts MS
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452006
[TBL] [Abstract][Full Text] [Related]
40. Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models.
Freitag TL; Fagerlund R; Karam NL; Leppänen VM; Ugurlu H; Kant R; Mäkinen P; Tawfek A; Jha SK; Strandin T; Leskinen K; Hepojoki J; Kesti T; Kareinen L; Kuivanen S; Koivulehto E; Sormunen A; Laidinen S; Khattab A; Saavalainen P; Meri S; Kipar A; Sironen T; Vapalahti O; Alitalo K; Ylä-Herttuala S; Saksela K
Vaccine; 2023 May; 41(20):3233-3246. PubMed ID: 37085458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
